Sort
15,440 grants matching “organoids”
Culture of tumor versus normal cells
$364,140Tan A. Ince · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Project 1--Targeted therapies for pediatric low-grade astrocytoma (Eck/Wright/Haas)
$364,103Daphne A. Haas-Kogan · Brigham And Women'S Hospital · P50 · FY2020 · CA
Monolithic 3D Neuroelectronics from BEOL Deterministic Rolling
$364,082Hui Fang · Dartmouth College · · FY2024 · ENG
Artificial thymic organoid platform to study T cell development and HIV/SIV infection using SIV/macaque model of HIV/AIDS
$364,000Sheikh Abdul Rahman · Emory University · R21 · FY2025 · OD
Artificial thymic organoid platform to study T cell development and HIV/SIV infection using SIV/macaque model of HIV/AIDS
$364,000Sheikh Abdul Rahman · Emory University · R21 · FY2024 · OD
Localizing Pathogenically Relevant Transglutaminase 2 in Celiac Disease
$363,968Chaitan Khosla · Stanford University · R01 · FY2021 · DK
Elucidating the Role of Perivascular Niche in Glioblastoma Invasion and Therapeutic Resistance at Single Cell Resolution using Biomimetic Tumor Microenvironment Models
$363,880Mehdi Nikkhah · Arizona State University-Tempe Campus · R01 · FY2024 · NS
Project 1: Modeling tumor evolution in mouse and organoid models
$363,795Raul Rabadan · Columbia University Health Sciences · U54 · FY2016 · CA
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
$363,773Jing Yang · University Of California, San Diego · R01 · FY2025 · CA
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
$363,773Jing Yang · University Of California, San Diego · R01 · FY2022 · CA
HCMV infection downregulates nidogen 1 and myelin protein zero
$363,750Elizabeth A Fortunato · University Of Idaho · R01 · FY2025 · AI
Presence and role of Enteroendocrine Cells Residing at the Intestinal Crypt Base
$363,736Stephen Wank · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Mechanisms coupling DEK to oncogenesis
$363,713Lisa M. Privette Vinnedge · Cincinnati Childrens Hosp Med Ctr · R37 · FY2021 · CA
Mechanisms coupling DEK to oncogenesis
$363,713Lisa M. Privette Vinnedge · Cincinnati Childrens Hosp Med Ctr · R37 · FY2022 · CA
Sensitizing Ovarian Cancer To PARP inhibitor and platinum treatment
$363,713Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2021 · CA
Sensitizing Ovarian Cancer To PARP inhibitor and platinum treatment
$363,713Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2025 · CA
Mechanisms coupling DEK to oncogenesis
$363,713Lisa M. Privette Vinnedge · Cincinnati Childrens Hosp Med Ctr · R37 · FY2020 · CA
Galpha13 and pancreatic cancer progression
$363,556Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2018 · CA
Galpha13 and pancreatic cancer progression
$363,556Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2021 · CA
Galpha13 and pancreatic cancer progression
$363,556Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2020 · CA
Interplay of mammary luminal cells and environmental factors in establishing p53-deficient premalignant field
$363,522Zhe Li · Brigham And Women'S Hospital · R01 · FY2019 · CA
Colonic responses to vitamin D and aspirin in African- and European-Americans
$363,486Sonia Kupfer · University Of Chicago · R01 · FY2022 · CA
Optimizing Response to Immune Checkpoint Inhibitor Therapy for Breast Cancer: A Role for Inhibitors of the PI3K pathway
$363,453Ann Richmond · Vanderbilt University · R01 · FY2021 · CA
Overcoming chemoresistance in triple negative breast cancer
$363,419Ozgur Sahin · Medical University Of South Carolina · R01 · FY2023 · CA
A20 Mediated Regulation of Colitis and Spondyloarthritis
$363,375Averil I Ma · University Of California, San Francisco · R01 · FY2021 · DK